This stock is one of several featured in our latest research. For more small-cap opportunities with asymmetric return potential, read our free article: 10 High-Potential Small-Caps With Market Cap Under $1B.
We came across a bullish thesis on Prothena Corporation plc on BiotechBonanza’s Substack by AnotherBio. In this article, we will summarize the bulls’ thesis on PRTA. Prothena Corporation plc’s share was trading at $9.92 as of October 3rd. PRTA’s forward P/E was 33.90 according...
